| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |